Patents by Inventor Wei-Hsin Sun

Wei-Hsin Sun has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Indication of naphtho[2,3-F]quinoxaline-7,12-dione compound in alleviating pain
    Patent number: 9284281
    Abstract: Disclosed are naphtho[2,3-f]quinoxaline compounds and pharmaceutical composition thereof. The compounds of the invention have been demonstrated as having analgesic effects and therefore may be applicable for use as a novel agent in relieving acute or chronic pain.
    Type: Grant
    Filed: September 16, 2014
    Date of Patent: March 15, 2016
    Assignee: NATIONAL CENTRAL UNIVERSITY
    Inventors: Wei-Hsin Sun, Shir-Ly Huang, Hsu-Shan Hunag
  • Indication of anthra[2,1,c][1,2,5]thiadiazole-6,11-dione compound in alleviating pain
    Patent number: 9192602
    Abstract: Disclosed are anthra[2,1-c][1,2,5]thiadiazole-6,11-dione compounds and pharmaceutical composition thereof. The compounds of the invention have been demonstrated as having analgesic effects and therefore may be applicable for use as a novel agent in relieving acute or chronic pain.
    Type: Grant
    Filed: September 16, 2014
    Date of Patent: November 24, 2015
    Assignee: National Central University
    Inventors: Wei-Hsin Sun, Shir-Ly Huang, Hsu-Shan Huang
  • INDICATION OF NAPHTHO[2,3-F]QUINOXALINE-7,12-DIONE COMPOUND IN ALLEVIATING PAIN
    Publication number: 20150259302
    Abstract: Disclosed are naphtho[2,3-f]quinoxaline compounds and pharmaceutical composition thereof. The compounds of the invention have been demonstrated as having analgesic effects and therefore may be applicable for use as a novel agent in relieving acute or chronic pain.
    Type: Application
    Filed: September 16, 2014
    Publication date: September 17, 2015
    Applicant: NATIONAL CENTRAL UNIVERSITY
    Inventors: Wei-Hsin SUN, Shir-Ly HUANG, Hsu-Shan HUNAG
  • INDICATION OF ANTHRA[2,1,c][1,2,5]THIADIAZOLE-6,11-DIONE COMPOUND IN ALLEVIATING PAIN
    Publication number: 20150258073
    Abstract: Disclosed are anthra[2,1-c][1,2,5]thiadiazole-6,11-dione compounds and pharmaceutical composition thereof. The compounds of the invention have been demonstrated as having analgesic effects and therefore may be applicable for use as a novel agent in relieving acute or chronic pain.
    Type: Application
    Filed: September 16, 2014
    Publication date: September 17, 2015
    Applicant: NATIONAL CENTRAL UNIVERSITY
    Inventors: WEI-HSIN SUN, SHIR-LY HUANG, HSU-SHAN HUANG
  • USE OF TUMOR NECROSIS FACTOR (TNF) RECEPTOR-ASSOCIATED FACTOR 7 (TRAF7) AS BIOMARKER FOR SYSTEMIC LUPUS ERYTHEMATOSUS (SLE), METHOD AND KIT FOR DETECTING OF HUMAN WITH SLE
    Publication number: 20140349316
    Abstract: A use of tumor necrosis factor (TNF) receptor-associated factor 7 (TRAF7) as a biomarker for systemic lupus erythematosus (SLE) and a method and a kit for detecting human with SLE are provided. The kit for detecting human with SLE includes TRAF7 and anti-TRAF7 antibodies. The method for detecting human with SLE includes the following steps. A plasma sample is taken from a patient with suspected SLE. The ratio of TRAF7 to total protein in the plasma sample of the patient is compared with that in the plasma sample of normal people. If the ratio of TRAF7 to total protein in the plasma sample of the patient is higher than that of the normal people, then it is possible that the patient is suffering from SLE. TRAF7 can be used as a biomarker for SLE patients in active phase and with renal involvement.
    Type: Application
    Filed: November 26, 2013
    Publication date: November 27, 2014
    Applicant: National Central University
    Inventors: Shir-Ly Huang, Shin-Chang Lin, Wei-Hsin Sun